Download the eBook today! By providing direct support to participants from enrollment through the end of a clinical trial, logistics-management companies can help ease the
Clincierge is proud to support CISCRP in a new educational initiative to increase awareness about clinical research and the level of understanding among minority communities across the U.S.We have united to circulate an informative full-page advertorial spread highlighting the key importance of diversity in clinical studies to discover treatments that are effective for everyone.
Of the over 7,000 known rare diseases, only 5% currently have any form of treatment. With such staggering statistics, the need for increased awareness, education, and treatment options is imperative. This month we’ll be taking a deeper look at four rare diseases: Dysautonomia, Gaucher Disease, Niemann-Pick Disease, and Rett Syndrome.
Global Diversity Month: Improving Awareness, Patient Diversity, and Access in Rare Disease Clinical Trials
Members of ethnic communities around the globe suffer from rare diseases unique to their demographic group. Designing a trial and selecting participants with diverse backgrounds that proportionally represent each demographic group is one of the first steps a sponsor can take to create a diverse and inclusive clinical trial.
Featured in Applied Clinical Trials: Decentralized trials are the way of the future—yet it would be ill-advised to think of them as a one-size-fits-all solution.
Focus on the Patient and Your Trial Outcome, Not on Logistics
Learn more about improving your clinical trials.